کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6184385 1254209 2014 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Factors associated with clinical trial screening failures in gynecologic oncology
ترجمه فارسی عنوان
عوامل مرتبط با نقص غربالگری پرونده های بالینی در انکولوژی زنان
کلمات کلیدی
دادگاه بالینی به عنوان موضوع، مشارکت بیمار، امتناع از شرکت، دانش بهداشت، نگرش، عمل، زن
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
چکیده انگلیسی


- Physicians did not offer trials to patients deemed “poor candidates” even in the absence of exclusion criteria.
- Patients who declined often perceived a possibility of suffering personal harm with participation.
- Patients were significantly less likely to accept a trial during primary treatment than at recurrence.

ObjectiveLow enrollment of adult cancer patients in clinical trials is an ongoing challenge in cancer research. We sought to determine factors associated with clinical trial screening failures in women with gynecologic malignancies at a large urban university health system.MethodsA retrospective review was conducted of women with gynecologic malignancies who presented to an urban university system between 12/2009 and 12/2012. Data collected included demographic, clinico-pathologic and trial-related factors, as well as reasons for non-participation.ResultsTwo hundred twenty-one patients were eligible for a clinical trial. Of these, 44% participated while 56% did not. There were more screening failures when trials were offered at the time of primary treatment than at recurrence (62% vs. 38%, p = 0.001). There was no significant difference in participation based on age, ethnicity, hospital setting, payor status, family history, comorbidities, prior treatment, substance abuse, recent surgery or trial type. Of the non-participants, 62% declined the study due to perceived harm and 10% due to socio-economic barriers while 20% were excluded due to co-morbidities and 8% due to noncompliance.ConclusionsSignificantly more screening failures for clinical trials occurred when trials were offered at the time of primary treatment. The majority of patients declined based on perceived harm from enrolling in a clinical trial, although 20% of eligible patients were not offered enrollment despite not meeting any exclusion criteria. Our findings underscore the importance of appropriate counseling when offering clinical trials, as well as overcoming physician biases in deciding who is an appropriate candidate.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 134, Issue 3, September 2014, Pages 450-454
نویسندگان
, , , , , ,